
Molecular Neuroscience
Group
Shining Light on Neurodegeneration

Welcome

We are an interdisciplinary group investigating molecules and mechanisms causing brain cells to die in different neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis, and Huntington's disease.
For this we apply many cutting-edge tools ranging from atomic force and superresolution microscopy to microfluidics, multi electrode arrays and machine learning.
To find out more of what we do have a look at our research pages. Whether you are a potential student or collaborator, we look forward to hearing from you.
Our Research
Advancing Neurodegenerative Research
By integrating state-of-the-art imaging, AI-driven analysis, stem-cell models, and electrophysiology, our research bridges fundamental science and clinical applications. Through strong global collaborations, we aim to accelerate the development of innovative therapies and diagnostic tools for neurodegenerative diseases.
For inquiries or collaboration opportunities, contact our research team.
Our Members

is head of the Molecular Neuroscience Group, co-director of the Cambridge Infinitus Research Institute (CIRCE), and director of the Cambridge MPhil in Biotechnology. Gabi studied Biology at the Université de Fribourg, Switzerland and did her Ph.D. in Medicine on Neural Transplantation in Parkinson's disease at Lund University, Sweden. She has since set-up a centre in the application of modern biophysical methods for the study of mechanisms of neurodegenerative diseases.

joined the group in 2017. She studied Chemistry and she did her Ph.D. in immunology on tropical diseases at the University of Granada (Spain). In the molecular neuroscience group, she looks at the aggregation of α-synuclein and underlying mechanisms. The main focus of her work it to elucidate the role of α-synuclein using primary dopaminergic neurons.

joined the group in June 2021. He studied mechanical engineering and did his Ph.D. in acoustofluidics at the ETH Zurich (Switzerland). The main topic of Nino’s research is the use of microfluidic devices and acoustic manipulation for the study of neurodegenerative diseases in model organisms.

Yuqing is a final-year PhD student with a background in chemistry. After completing the MPhil in Biotechnology at the University of Cambridge, she is currently investigating the link between brain cholesterol and neurodegeneration using iPSC-derived neurons and super-resolution imaging.

Bel is a final-year PhD student working on the development of microphysiological systems (microfluidic chips) and organic bioelectronic systems (planar and flexible electrophysiology devices) to enhance functional characterisation of stem cell-derived neural models. She has a BSc in Mechanical Engineering (American University in Cairo, 2019) and an MSc in Photonics Technologies (Aix-Marseille and Tampere Universities, 2020/1).

Stefany received her BEng in Electrical and Electronics Engineering, from the University of Southampton in 2020. She then completed MRes in Sensor Technologies at the University of Cambridge. She is currently a final-year PhD student, studying the role of brain cholesterol in neurodegenerative diseases by fabricating biosensors from organic electrochemical transistors.

Sofia is a PhD student between the group and AstraZeneca. Her background is in chemistry and bioinformatics and her PhD involves investigating cellular responses to drug exposure using advanced microscopy techniques and machine learning.

Rohan joined the unit in 2022 as a PhD student. His work focuses on using human brain organoids to study Amyotrophic lateral sclerosis (ALS), a neurological disease that affects the neurons responsible for controlling voluntary muscle movement.

Jakob graduated with a BSc in Physics from LMU Munich. After completing the MPhil in Biotechnology at the University of Cambridge, he is now a PhD student using machine learning to study neuronal activity and brain elasticity.

Jieni studied bioengineering at Imperial College with a year abroad at ETH, then worked as a research assistant in the department of PDN. Jieni joined the sensor CDT in 2022 and completed a research project in MNG studying the local field potential of rat primary neurons in the presence of Tau.

Sulay is a second-year PhD student with a background in Electrical Engineering. After completing the MPhil in Biotechnology at the University of Cambridge, his work now focuses on integrating microelectrode arrays and microfluidics with disease models to investigate amyloid-beta pathology in Alzheimer’s Disease.

Prior to joining the Molecular Neuroscience Group, Josiah completed my undergraduate (MChem) degree in Chemistry at Loughborough University, UK, with a year abroad at Curtin University, Australia, and his post-graduate master's degree in Nanoscience & Nanotechnology at the University of Cambridge, UK.

Francesco is a first-year PhD student with a background in bioengineering. He earned his MEng from Imperial College London in 2023 before joining Sensor CDT, where he completed his MRes in 2024. His research focuses on developing tools and techniques to study human brain organoids, with the goal of uncovering the underlying mechanisms of neurodegenerative diseases.

is a Visiting Researcher who is currently on a gap year funded by the Hotchkiss MacArthur Fellowship. He is working on a python interface that can handle the filtering, analyzing, and modeling of data gathered from the mini brains.